There are previous studies that have linked PSMA levels measured on primary prostatectomy specimens with CaP outcome, and increased PSMA expression has been associated with higher tumor grade [9], and metastatic disease [60,61]. The gene discussed is FOLH1; the disease is metastatic neoplasm.